カテゴリ： MarketLine, スイス, 企業調査

CRISPR Therapeutics：戦略・SWOT・企業財務分析

◆英語タイトル：CRISPR Therapeutics - Strategy, SWOT and Corporate Finance Report
◆商品コード：DATA8015021
◆発行会社（調査会社）：MarketLine
◆発行日：2017年9月30日
◆ページ数：47
◆レポート言語：英語
◆レポート形式：PDF
◆納品方法：Eメール
◆対象地域：スイス
◆産業分野：製薬・医療
◆販売価格オプション（消費税別）
Single UserUSD175 ⇒換算￥25,900見積依頼/購入/質問フォーム
Site License（同一事業所内共有可）USD350 ⇒換算￥51,800見積依頼/購入/質問フォーム
Enterprisewide License（複数事業所内共有可）USD525 ⇒換算￥77,700見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※本体価格が￥30,000未満のレポートにつきましては、ハンドリングチャージ￥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketLine社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
※MarketLine社の概要はこちらでご確認いただけます。

このエントリーをはてなブックマークに追加
LINEで送る


【レポートの概要】

CRISPR Therapeutics – Strategy, SWOT and Corporate Finance Report
Summary

CRISPR Therapeutics – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.

Key Highlights

CRISPR Therapeutics AG (CRISPR or “the company”) is a biopharmaceutical company created to translate CRISPR-Cas9, a breakthrough gene-editing technology, into transformative medicines for serious human diseases. The company classifies its business into single operating segment: the business of discovering, developing and commercializing therapies derived from or incorporating genome-editing technology. Through its CRISPR/Cas9 gene-editing technology, the company allows selective deletion, modification or correction of a disease causing abnormality in a specific DNA segment. It primarily operates in Switzerland, the UK, and the US. The company is headquartered in Basel, Switzerland.

Scope

- Detailed information on CRISPR Therapeutics required for business and competitor intelligence needs
- A study of the major internal and external factors affecting CRISPR Therapeutics in the form of a SWOT analysis
- An in-depth view of the business model of CRISPR Therapeutics including a breakdown and examination of key business segments
- Intelligence on CRISPR Therapeutics’s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about CRISPR Therapeutics, such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

- Gain understanding of CRISPR Therapeutics and the factors that influence its strategies.
- Track strategic initiatives of the company and latest corporate news and actions.
- Assess CRISPR Therapeutics as a prospective partner, vendor or supplier.
- Support sales activities by understanding your customers’ businesses better.
- Stay up to date on CRISPR Therapeutics’s business structure, strategy and prospects.

【レポートの目次】

Table of Contents
Company Snapshot
CRISPR Therapeutics: Company Overview
CRISPR Therapeutics: Overview and Key Facts
CRISPR Therapeutics: Overview
CRISPR Therapeutics: Key Facts
CRISPR Therapeutics: Key Employees
CRISPR Therapeutics: Key Employee Biographies
CRISPR Therapeutics: Major Products and Services
CRISPR Therapeutics: Company History
CRISPR Therapeutics: Management Statement
CRISPR Therapeutics: Key Competitors
CRISPR Therapeutics: Company Analysis
CRISPR Therapeutics: Business Description
CRISPR Therapeutics: SWOT Analysis
CRISPR Therapeutics: SWOT Overview
CRISPR Therapeutics: Strengths
CRISPR Therapeutics: Weaknesses
CRISPR Therapeutics: Opportunities
CRISPR Therapeutics: Threats
CRISPR Therapeutics: Corporate Financial Deals Activity
CRISPR Therapeutics: Financial Deals Overview
CRISPR Therapeutics: Targets and Partners
CRISPR Therapeutics: Top Deals 2013 – 2017YTD*
CRISPR Therapeutics: Advisors
CRISPR Therapeutics: Top Legal Advisors
CRISPR Therapeutics: Top Financial Advisors
CRISPR Therapeutics: Capital Raising
CRISPR Therapeutics: Partnership
CRISPR Therapeutics: Private Equity and Ownership
CRISPR Therapeutics: Recent Developments
CRISPR Therapeutics: News and Events Summary
CRISPR Therapeutics: Business Expansion
CRISPR Therapeutics: Corporate Governance
CRISPR Therapeutics: Financial Deals
CRISPR Therapeutics: Financial Performance
CRISPR Therapeutics: Grants
CRISPR Therapeutics: Market Developments
CRISPR Therapeutics: Regulatory and Legal Events
CRISPR Therapeutics: Research & Development
CRISPR Therapeutics: Strategy and Operations
Appendix
Contact Us
Methodology
Definitions
About MarketLine

List of Tables
Table 1: CRISPR Therapeutics: Key Facts
Table 2: CRISPR Therapeutics: Key Employees
Table 3: CRISPR Therapeutics: Key Competitors
Table 4: CRISPR Therapeutics: Deal Activity by Deal Type - Volume (TTM*)
Table 5: CRISPR Therapeutics: Deal Activity by Deal Type - Volume (2013 - YTD*2017)
Table 6: CRISPR Therapeutics: Targets and Partners
Table 7: CRISPR Therapeutics: Top Deals 2013 - 2017YTD*
Table 8: CRISPR Therapeutics: Legal Advisor Ranking by Value (US$m)
Table 9: CRISPR Therapeutics: Financial Advisor Ranking by Value (US$m)
Table 10: CRISPR Therapeutics: Capital Raising Volume and Value Trend (2013 - YTD*2017)
Table 11: CRISPR Therapeutics: Capital Raising by Deal Type (2013 - YTD*2017)
Table 12: CRISPR Therapeutics: Partnership Volume and Value Trend (2013 - YTD*2017)
Table 13: CRISPR Therapeutics: Partnership Trend by Deal Type (2013 - YTD*2017)
Table 14: CRISPR Therapeutics: Private Equity and Ownership Volume and Value Trend (2013 - YTD*2017)
Table 15: CRISPR Therapeutics: Private Equity and Ownership Volume by Deal Type (2013 - YTD*2017)
Table 16: CRISPR Therapeutics: News and Events Summary
Table 17: CRISPR Therapeutics: Business Expansion
Table 18: CRISPR Therapeutics: Corporate Governance
Table 19: CRISPR Therapeutics: Financial Deals
Table 20: CRISPR Therapeutics: Financial Performance
Table 21: CRISPR Therapeutics: Grants
Table 22: CRISPR Therapeutics: Market Developments
Table 23: CRISPR Therapeutics: Regulatory and Legal Events
Table 24: CRISPR Therapeutics: Research & Development
Table 25: CRISPR Therapeutics: Strategy and Operations

★海外企業調査レポート[CRISPR Therapeutics：戦略・SWOT・企業財務分析]についてメールでお問い合わせはこちら
■おすすめ企業レポート■
  • Electricity Authority of Cyprus：企業の戦略的SWOT分析
    Electricity Authority of Cyprus - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major pro …
  • Younicos AG：電力：M&Aディール及び事業提携情報
    Summary Younicos AG (Younicos), a subsidiary of Aggreko Plc, is a provider of smart energy and grid solutions based on battery storage technology. The company offers Y-Cube plug and play energy storage solution, Y-Station building solution, and Y-Q software platform. It also provides battery packs u …
  • Shibuya Kogyo Co., Ltd.：企業の戦略・SWOT・財務情報
    Shibuya Kogyo Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary Shibuya Kogyo Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Gliknik Inc：製薬・医療：M&Aディール及び事業提携情報
    Summary Gliknik Inc (Gliknik) is a biopharmaceutical company that develops therapies for patients suffering from cancer and immune disorders. The company’s pipeline products include biropepimut-S (GL-0817) and GL-2045. Its biropepimut-S is an engineered peptide immunomodulator targeted against impor …
  • Shamrock Foods Company：企業の戦略的SWOT分析
    Shamrock Foods Company - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • ProterixBio Inc：医療機器：M&Aディール及び事業提携情報
    Summary ProterixBio Inc (ProterixBio), formerly BioScale Inc, is a medical device company that manufactures and markets ViBE platform products. The company offers ViBE platform, acoustic assays, ViBE software and custom assays, among others. Its ViBE platform enables non-optical detection and sensit …
  • TesoRx Pharma LLC：製薬・医療：M&Aディール及び事業提携情報
    Summary TesoRx Pharma LLC (TesoRx) is a pharmaceutical company that develops treatments to address unmet medical needs. The company’s product pipeline comprises TSD-001, TSD-005, TSX-011 and TSX-002. Its TSD-001is an intravesical paclitaxel for the treatment of non-muscle invasive bladder cancer. Te …
  • Cinnabon LLC：企業の戦略・SWOT・財務情報
    Cinnabon LLC - Strategy, SWOT and Corporate Finance Report Summary Cinnabon LLC - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • DPR Construction Inc：企業の戦略的SWOT分析
    DPR Construction Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and s …
  • AEP Industries Inc (AEPI)：企業の財務・戦略的SWOT分析
    Summary AEP Industries Inc (AEP), a subsidiary of Berry Plastics Group Inc, is a plastic packaging film provider that manufactures and markets multi-purpose and flexible packaging films. The company offers custom films such as shrink film, poly bags, tubing, construction film, sheeting, sheets, shri …
  • Kapsch TrafficCom AG (KTCG)：企業の財務・戦略的SWOT分析
    Kapsch TrafficCom AG (KTCG) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • Puma Energy Holdings Pte Ltd：石油・ガス：M&Aディール及び事業提携情報
    Summary Puma Energy Holdings Pte Ltd (Puma Energy) is an integrated midstream and downstream energy company. Its midstream operations include the supply, storage and transportation of petroleum products. The company’s downstream operations include the distribution, retail sales and wholesale of a wi …
  • Korber AG：戦略・SWOT・企業財務分析
    Korber AG - Strategy, SWOT and Corporate Finance Report Summary Korber AG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions …
  • CRH public limited company (CRG)：企業の財務・戦略的SWOT分析
    CRH public limited company (CRG) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and wea …
  • Enbridge Energy Partners LP (EEP)：電力：M&Aディール及び事業提携情報
    Summary Enbridge Energy Partners LP (EEP) is a midstream energy partnership that owns and operates a diversified portfolio of crude oil and liquids transportation systems in the US. It provides services through interstate pipeline transportation and storage of crude oil and liquid petroleum. The par …
  • Zimmer Biomet Holdings Inc (ZBH)：企業の財務・戦略的SWOT分析
    Zimmer Biomet Holdings Inc (ZBH) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and wea …
  • Almirall SA (ALM)：企業の財務・戦略的SWOT分析
    Almirall SA (ALM) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Aditya Birla Retail Ltd：企業の戦略的SWOT分析
    Aditya Birla Retail Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products an …
  • Vietnam National Oil and Gas Group：石油・ガス：M&Aディール及び事業提携情報
    Summary Vietnam National Oil and Gas Group (Petrovietnam) is an oil and gas exploration and production company. The company conducts petroleum activities and signs petroleum contracts with organizations and individuals. Its services include oil and natural gas exploration and production, petroleum a …
  • Guangzhou R&F Properties Co Ltd：戦略・SWOT・企業財務分析
    Guangzhou R&F Properties Co Ltd - Strategy, SWOT and Corporate Finance Report Summary Guangzhou R&F Properties Co Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product …

◆H&Iグローバルリサーチ株式会社のお客様（例）◆